CRISPR-Cas9 MODIFIED HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS AND ASSOCIATED USES

MA51107AUndetermined Publication Date: 2020-10-14VERTEX PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA51107
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-09-21
Filing Date
2018-12-05
Publication Date
2020-10-14
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.